We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 472

Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals Inc., No. 18-1638, Courtroom 201
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • June 1 2018

In this appeal from the PTAB, the Federal Circuit has been asked to consider whether the Saint Regis Mohawk Native American Tribe may assert sovereign


Tribal Sovereign Immunity Alone Cannot Protect Patents from IPR
  • Marshall Gerstein & Borun LLP
  • USA
  • May 4 2018

In late March, the Federal Circuit issued an order staying the PTAB proceedings concerning numerous related IPRs of patents issued to Allergan, Inc


Fujifilm and Mylan Announce Partnership to Commercialize Adalimumab Biosimilar
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • April 20 2018

Fujifilm Kyowa Kirin Biologics Co., Ltd. (“Fujifilm”) recently announced that it will partner with Mylan N.V. (“Mylan”) to commercialize a biosimilar


Southern District Of New York Denies Motion To Dismiss Exchange Act Claims Against Mylan Regarding EpiPen
  • Shearman & Sterling LLP
  • USA
  • April 3 2018

On March 28, 2018, Judge J. Paul Oetken of the United States District Court for the Southern District of New York granted in part and denied in part a


Global Approvals for Insulin Glargine Promise a More Affordable, Long-Acting Treatment for Diabetes
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • April 3 2018

Last week, Mylan N.V. and Biocon Ltd. announced that their jointly-developed insulin glargine biosimilar, Semglee, received marketing approval from


Tribal sovereign immunity does not apply to PTAB proceedings
  • Baker Donelson Bearman Caldwell & Berkowitz PC
  • USA
  • March 7 2018

On February 23 2018 a panel of three administrative patent judges at the Patent Trial and Appeal Board (PTAB) unanimously agreed that tribal sovereign


Join the Party! CAFC Hears IPR Appeal From Parties That Were Time-Barred From Filing Petition
  • Marshall Gerstein & Borun LLP
  • USA
  • March 6 2018

Research Corporation Technologies, Inc. (RCT) sued Mylan Pharmaceuticals, Inc. (Mylan), Breckenridge Pharmaceutical, Inc. (Breckinridge), and Alembic


Tribal Sovereign Immunity Doctrine Does Not Insulate Tribes From Board Actions
  • Jones Day
  • USA
  • February 27 2018

In a case of first impression, the PTAB recently decided that the doctrine of tribal sovereign immunity does not apply to inter partes review


Allergan’s Mohawk Gambit Fails at the PTAB
  • Pepper Hamilton LLP
  • USA
  • February 27 2018

The Patent Trial and Appeal Board (PTAB) has not taken kindly to a move by the Irish drug company Allergan to shield its key patents on its dry-eye


The Potential Impact of the Supreme Court’s Decision in Oil States
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • November 23 2017

On November 27, 2017, in Oil States Energy Services, LLC v. Greene’s Energy Group, LLC, the Supreme Court will hold oral argument to determine the